MCC
MRNA icon

Money Concepts Capital’s Moderna MRNA Stock Holding History

Money Concepts Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,890
Closed -$1.13M – 416
2024
Q3 		$1.13M Buy
16,890
+26
+0.2% +$2.39K 0.09% 197
2024
Q2 		$2M Buy
16,864
+7,768
+85% +$983K 0.17% 139
2024
Q1 		$969K Buy
9,096
+892
+11% +$89.9K 0.09% 208
2023
Q4 		$816K Buy
+8,204
New +$690K 0.08% 218
2023
Q3 		– Sell
-5,977
Closed -$726K – 369
2023
Q2 		$726K Buy
5,977
+157
+3% +$20.9K 0.07% 225
2023
Q1 		$894K Sell
5,820
-175
-3% -$28.9K 0.05% 232
2022
Q4 		$1.08M Buy
5,995
+441
+8% +$72.1K 0.05% 280
2022
Q3 		$657K Buy
5,554
+317
+6% +$48.1K 0.04% 268
2022
Q2 		$785K Sell
5,237
-313
-6% -$44.7K 0.07% 219
2022
Q1 		$956K Buy
5,550
+931
+20% +$157K 0.05% 307
2021
Q4 		$1.17M Buy
+4,619
New +$1.35M 0.1% 198

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Money Concepts Capital's MRNA Position: Q4 2024 in Review

Money Concepts Capital sold out of Moderna (MRNA) in Q4 2024, closing a stake of 16,890 shares — an estimated $1.13M sold.

Money Concepts Capital first reported a position in MRNA in Q4 2021 and held it in 11 quarters. The position peaked at $2M in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Money Concepts Capital reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Money Concepts Capital sold 16,890 Moderna shares in Q4 2024, an estimated $1.13M.
  • Money Concepts Capital first reported a position in Moderna in Q4 2021 and held it in 11 quarters.
  • Money Concepts Capital's Moderna position peaked at $2M in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Money Concepts Capital's 13F filing for Q4 2024, filed 27 Jan 2025.